Korsana Biosciences, Inc. (KRSA) vs Ultragenyx Pharmaceutical Inc. (RARE)
- Korsana Biosciences, Inc. KRSA 32.38 −3.77%
- Ultragenyx Pharmaceutical Inc. RARE 14.54 −4.15%
Korsana Biosciences, Inc. and Ultragenyx Pharmaceutical Inc. are both Biotechnology companies. Korsana Biosciences, Inc. and Ultragenyx Pharmaceutical Inc. are of similar size ($1.5B and $1.5B). Korsana Biosciences, Inc. grew revenue faster over the last twelve months: 30.8% against 17.5%. Korsana Biosciences, Inc. has the higher net margin (0.00% vs −81.7%) and the lower return on invested capital (−115.4% vs 0.00%). Across the 16 metrics below, Korsana Biosciences, Inc. leads on 9 and Ultragenyx Pharmaceutical Inc. on 7.
Valuation
Profitability
| Metric | KRSA | RARE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 83.12% | 65.16% |
| Operating margin | 0.00% | (73.64%) | 0.00% |
| Net margin | 0.00% | (81.73%) | 0.00% |
| Free cash flow margin | 0.00% | (68.90%) | 0.00% |
| Return on equity | (98.22%) | 838.86% | (56.36%) |
| Return on assets | (82.29%) | (45.60%) | (48.04%) |
| Return on invested capital | (115.40%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack